Endeavor

CancerX Partnership Tackles Disparities and Financial Toxicity in Cancer Care and Research

Launched in 2023, CancerX is part of the White House Cancer Moonshot initiative

New Treatment Reduces Need for Blood Transfusions for Patients with Certain Blood Cancers, Study Shows

Almost 40% of patients with lower risk myelodysplastic syndromes achieved eight-week transfusion independence with imetelstat, study shows

Already Approved Drug Shows Promise in Patients with MDS/MPN Overlapping Syndromes

Moffitt launched trial investigates myelofibrosis drug in rare patient population

Looking at Guided Radiation for Triple-Negative Breast Cancer

A new study personalizes radiation therapy doses for patients based on their tumor profile

Special Recognition for the Specialty Pharmacy

New accreditations open doors to reduce medication costs for patients

Using Contemporary Data to Better Classify Blood Clot Risk in Polycythemia Vera Patients

Study shows age is less of a factor than medical history when it comes to risk for thrombosis

PEARL: Exploring More Personalized Prevention, Screening and Treatment

The Population Engagement and Research Laboratory brings together researchers on diet, exercise, smoking cessation and other areas to work toward devising more personalized interventions

Nonmedical Factors Can Significantly Impact Your Health

What are social determinants of health and how is Moffitt addressing them?

Arts in Medicine Celebrates 25 Years

What started as a single art cart is now a comprehensive service for patients, families and staff